APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Recombinant FVIII

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Recombinant FVIII Market Analysis and Forecast 2026-2032

Report ID 17403140021 January 2026193 pages

Choose your research edition.

Industry ResearchRecombinant FVIII Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant FVIII Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Recombinant FVIII Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant FVIII Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant FVIII Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Recombinant FVIII market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Recombinant FVIII is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Recombinant FVIII is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Recombinant FVIII is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Recombinant FVIII is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Recombinant FVIII include Sinocelltech, Comirnaty, Novo Nordisk, Green Cross, Bayer and Baxter, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Recombinant FVIII, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Recombinant FVIII, also provides the sales of main regions and countries. Of the upcoming market potential for Recombinant FVIII, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Recombinant FVIII sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Recombinant FVIII market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Recombinant FVIII sales, projected growth trends, production technology, application and end-user industry.

Recombinant FVIII Segment by Company

Sinocelltech

Comirnaty

Novo Nordisk

Green Cross

Bayer

Baxter

Recombinant FVIII Segment by Type

1000 IU/bottle

2000 IU/bottle

250 IU/bottle

500 IU/bottle

Recombinant FVIII Segment by Application

Teenagers

Adults

Recombinant FVIII Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant FVIII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant FVIII and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant FVIII.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Recombinant FVIII in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Recombinant FVIII manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant FVIII sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Recombinant FVIII Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 1000 IU/bottle Major Manufacturers Table 3. 2000 IU/bottle Major Manufacturers Table 4. 250 IU/bottle Major Manufacturers Table 5. 500 IU/bottle Major Manufacturers Table 6. Global Recombinant FVIII Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Teenagers Major Manufacturers Table 8. Adults Major Manufacturers Table 9. Recombinant FVIII Industry Trends Table 10. Recombinant FVIII Industry Drivers Table 11. Recombinant FVIII Industry Opportunities and Challenges Table 12. Recombinant FVIII Industry Restraints Table 13. Global Recombinant FVIII Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Recombinant FVIII Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Recombinant FVIII Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Recombinant FVIII Revenue Market Share by Region (2021-2026) Table 17. Global Recombinant FVIII Revenue Market Share by Region (2027-2032) Table 18. Global Recombinant FVIII Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Recombinant FVIII Sales by Region (2021-2026) & (K Units) Table 20. Global Recombinant FVIII Sales by Region (2027-2032) & (K Units) Table 21. Global Recombinant FVIII Sales Market Share by Region (2021-2026) Table 22. Global Recombinant FVIII Sales Market Share by Region (2027-2032) Table 23. Global Recombinant FVIII Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Recombinant FVIII Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Recombinant FVIII Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Recombinant FVIII Sales Market Share by Manufacturers (2021-2026) Table 27. Global Recombinant FVIII Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Recombinant FVIII Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Recombinant FVIII Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Recombinant FVIII Manufacturers, Product Type & Application Table 31. Global Recombinant FVIII Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Recombinant FVIII by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Recombinant FVIII Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Recombinant FVIII Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Recombinant FVIII Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Recombinant FVIII Revenue Market Share by Type (2021-2026) Table 38. Global Recombinant FVIII Revenue Market Share by Type (2027-2032) Table 39. Global Recombinant FVIII Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Recombinant FVIII Sales by Type (2021-2026) & (K Units) Table 41. Global Recombinant FVIII Sales by Type (2027-2032) & (K Units) Table 42. Global Recombinant FVIII Sales Market Share by Type (2021-2026) Table 43. Global Recombinant FVIII Sales Market Share by Type (2027-2032) Table 44. Global Recombinant FVIII Price by Type (2021-2026) & (US$/Unit) Table 45. Global Recombinant FVIII Price by Type (2027-2032) & (US$/Unit) Table 46. Global Recombinant FVIII Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Recombinant FVIII Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Recombinant FVIII Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Recombinant FVIII Revenue Market Share by Application (2021-2026) Table 50. Global Recombinant FVIII Revenue Market Share by Application (2027-2032) Table 51. Global Recombinant FVIII Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Recombinant FVIII Sales by Application (2021-2026) & (K Units) Table 53. Global Recombinant FVIII Sales by Application (2027-2032) & (K Units) Table 54. Global Recombinant FVIII Sales Market Share by Application (2021-2026) Table 55. Global Recombinant FVIII Sales Market Share by Application (2027-2032) Table 56. Global Recombinant FVIII Price by Application (2021-2026) & (US$/Unit) Table 57. Global Recombinant FVIII Price by Application (2027-2032) & (US$/Unit) Table 58. Sinocelltech Company Information Table 59. Sinocelltech Business Overview Table 60. Sinocelltech Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Sinocelltech Recombinant FVIII Product Portfolio Table 62. Sinocelltech Recent Development Table 63. Comirnaty Company Information Table 64. Comirnaty Business Overview Table 65. Comirnaty Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Comirnaty Recombinant FVIII Product Portfolio Table 67. Comirnaty Recent Development Table 68. Novo Nordisk Company Information Table 69. Novo Nordisk Business Overview Table 70. Novo Nordisk Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Novo Nordisk Recombinant FVIII Product Portfolio Table 72. Novo Nordisk Recent Development Table 73. Green Cross Company Information Table 74. Green Cross Business Overview Table 75. Green Cross Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Green Cross Recombinant FVIII Product Portfolio Table 77. Green Cross Recent Development Table 78. Bayer Company Information Table 79. Bayer Business Overview Table 80. Bayer Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Bayer Recombinant FVIII Product Portfolio Table 82. Bayer Recent Development Table 83. Baxter Company Information Table 84. Baxter Business Overview Table 85. Baxter Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Baxter Recombinant FVIII Product Portfolio Table 87. Baxter Recent Development Table 88. North America Recombinant FVIII Revenue by Type (2021-2026) & (US$ Million) Table 89. North America Recombinant FVIII Revenue by Type (2027-2032) & (US$ Million) Table 90. North America Recombinant FVIII Sales by Type (2021-2026) & (K Units) Table 91. North America Recombinant FVIII Sales by Type (2027-2032) & (K Units) Table 92. North America Recombinant FVIII Sales Price by Type (2021-2026) & (US$/Unit) Table 93. North America Recombinant FVIII Sales Price by Type (2027-2032) & (US$/Unit) Table 94. North America Recombinant FVIII Revenue by Application (2021-2026) & (US$ Million) Table 95. North America Recombinant FVIII Revenue by Application (2027-2032) & (US$ Million) Table 96. North America Recombinant FVIII Sales by Application (2021-2026) & (K Units) Table 97. North America Recombinant FVIII Sales by Application (2027-2032) & (K Units) Table 98. North America Recombinant FVIII Sales Price by Application (2021-2026) & (US$/Unit) Table 99. North America Recombinant FVIII Sales Price by Application (2027-2032) & (US$/Unit) Table 100. North America Recombinant FVIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Recombinant FVIII Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. North America Recombinant FVIII Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. North America Recombinant FVIII Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 104. North America Recombinant FVIII Sales by Country (2021-2026) & (K Units) Table 105. North America Recombinant FVIII Sales by Country (2027-2032) & (K Units) Table 106. North America Recombinant FVIII Sales Price by Country (2021-2026) & (US$/Unit) Table 107. North America Recombinant FVIII Sales Price by Country (2027-2032) & (US$/Unit) Table 108. United States Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 109. Canada Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 110. Europe Recombinant FVIII Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Recombinant FVIII Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Recombinant FVIII Sales by Type (2021-2026) & (K Units) Table 113. Europe Recombinant FVIII Sales by Type (2027-2032) & (K Units) Table 114. Europe Recombinant FVIII Sales Price by Type (2021-2026) & (US$/Unit) Table 115. Europe Recombinant FVIII Sales Price by Type (2027-2032) & (US$/Unit) Table 116. Europe Recombinant FVIII Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Recombinant FVIII Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Recombinant FVIII Sales by Application (2021-2026) & (K Units) Table 119. Europe Recombinant FVIII Sales by Application (2027-2032) & (K Units) Table 120. Europe Recombinant FVIII Sales Price by Application (2021-2026) & (US$/Unit) Table 121. Europe Recombinant FVIII Sales Price by Application (2027-2032) & (US$/Unit) Table 122. Europe Recombinant FVIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Recombinant FVIII Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. Europe Recombinant FVIII Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. Europe Recombinant FVIII Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 126. Europe Recombinant FVIII Sales by Country (2021-2026) & (K Units) Table 127. Europe Recombinant FVIII Sales by Country (2027-2032) & (K Units) Table 128. Europe Recombinant FVIII Sales Price by Country (2021-2026) & (US$/Unit) Table 129. Europe Recombinant FVIII Sales Price by Country (2027-2032) & (US$/Unit) Table 130. Germany Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 131. France Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 132. U.K. Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 133. Italy Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 134. Netherlands Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 135. China Recombinant FVIII Revenue by Type (2021-2026) & (US$ Million) Table 136. China Recombinant FVIII Revenue by Type (2027-2032) & (US$ Million) Table 137. China Recombinant FVIII Sales by Type (2021-2026) & (K Units) Table 138. China Recombinant FVIII Sales by Type (2027-2032) & (K Units) Table 139. China Recombinant FVIII Sales Price by Type (2021-2026) & (US$/Unit) Table 140. China Recombinant FVIII Sales Price by Type (2027-2032) & (US$/Unit) Table 141. China Recombinant FVIII Revenue by Application (2021-2026) & (US$ Million) Table 142. China Recombinant FVIII Revenue by Application (2027-2032) & (US$ Million) Table 143. China Recombinant FVIII Sales by Application (2021-2026) & (K Units) Table 144. China Recombinant FVIII Sales by Application (2027-2032) & (K Units) Table 145. China Recombinant FVIII Sales Price by Application (2021-2026) & (US$/Unit) Table 146. China Recombinant FVIII Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Asia Recombinant FVIII Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Recombinant FVIII Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Recombinant FVIII Sales by Type (2021-2026) & (K Units) Table 150. Asia Recombinant FVIII Sales by Type (2027-2032) & (K Units) Table 151. Asia Recombinant FVIII Sales Price by Type (2021-2026) & (US$/Unit) Table 152. Asia Recombinant FVIII Sales Price by Type (2027-2032) & (US$/Unit) Table 153. Asia Recombinant FVIII Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Recombinant FVIII Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Recombinant FVIII Sales by Application (2021-2026) & (K Units) Table 156. Asia Recombinant FVIII Sales by Application (2027-2032) & (K Units) Table 157. Asia Recombinant FVIII Sales Price by Application (2021-2026) & (US$/Unit) Table 158. Asia Recombinant FVIII Sales Price by Application (2027-2032) & (US$/Unit) Table 159. Asia Recombinant FVIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Recombinant FVIII Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia Recombinant FVIII Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia Recombinant FVIII Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 163. Asia Recombinant FVIII Sales by Country (2021-2026) & (K Units) Table 164. Asia Recombinant FVIII Sales by Country (2027-2032) & (K Units) Table 165. Asia Recombinant FVIII Sales Price by Country (2021-2026) & (US$/Unit) Table 166. Asia Recombinant FVIII Sales Price by Country (2027-2032) & (US$/Unit) Table 167. Japan Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 168. South Korea Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 169. India Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 170. Australia Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 171. China Taiwan Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 173. SAMEA Recombinant FVIII Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Recombinant FVIII Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Recombinant FVIII Sales by Type (2021-2026) & (K Units) Table 176. SAMEA Recombinant FVIII Sales by Type (2027-2032) & (K Units) Table 177. SAMEA Recombinant FVIII Sales Price by Type (2021-2026) & (US$/Unit) Table 178. SAMEA Recombinant FVIII Sales Price by Type (2027-2032) & (US$/Unit) Table 179. SAMEA Recombinant FVIII Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Recombinant FVIII Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Recombinant FVIII Sales by Application (2021-2026) & (K Units) Table 182. SAMEA Recombinant FVIII Sales by Application (2027-2032) & (K Units) Table 183. SAMEA Recombinant FVIII Sales Price by Application (2021-2026) & (US$/Unit) Table 184. SAMEA Recombinant FVIII Sales Price by Application (2027-2032) & (US$/Unit) Table 185. SAMEA Recombinant FVIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Recombinant FVIII Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA Recombinant FVIII Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA Recombinant FVIII Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 189. SAMEA Recombinant FVIII Sales by Country (2021-2026) & (K Units) Table 190. SAMEA Recombinant FVIII Sales by Country (2027-2032) & (K Units) Table 191. SAMEA Recombinant FVIII Sales Price by Country (2021-2026) & (US$/Unit) Table 192. SAMEA Recombinant FVIII Sales Price by Country (2027-2032) & (US$/Unit) Table 193. Brazil Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 194. Argentina Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 195. Chile Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 196. Colombia Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 197. Peru Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 199. Israel Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 200. UAE Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 201. Turkey Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 202. Iran Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 203. Egypt Recombinant FVIII Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Recombinant FVIII Distributors List Table 207. Recombinant FVIII Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Recombinant FVIII Image Figure 2. Global Recombinant FVIII Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant FVIII Market Size Share 2021 VS 2025 VS 2032 Figure 4. 1000 IU/bottle Image Figure 5. 2000 IU/bottle Image Figure 6. 250 IU/bottle Image Figure 7. 500 IU/bottle Image Figure 8. Global Recombinant FVIII Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Recombinant FVIII Market Size Share 2021 VS 2025 VS 2032 Figure 10. Teenagers Image Figure 11. Adults Image Figure 12. Global Recombinant FVIII Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Recombinant FVIII Revenue (2021-2032) & (US$ Million) Figure 14. Global Recombinant FVIII Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Recombinant FVIII Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Recombinant FVIII Revenue Market Share by Region (2021-2032) Figure 17. Global Recombinant FVIII Sales (2021-2032) & (K Units) Figure 18. Global Recombinant FVIII Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Recombinant FVIII Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Recombinant FVIII Sales YoY (2021-2032) & (K Units) Figure 21. Europe Recombinant FVIII Sales YoY (2021-2032) & (K Units) Figure 22. China Recombinant FVIII Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Recombinant FVIII Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Recombinant FVIII Sales YoY (2021-2032) & (K Units) Figure 25. Global Recombinant FVIII Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Recombinant FVIII Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Recombinant FVIII Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Recombinant FVIII Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Recombinant FVIII Revenue Market Share by Type (2021-2032) Figure 31. Global Recombinant FVIII Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Recombinant FVIII Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Recombinant FVIII Sales Market Share by Type (2021-2032) Figure 34. Global Recombinant FVIII Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Recombinant FVIII Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Recombinant FVIII Revenue Market Share by Application (2021-2032) Figure 37. Global Recombinant FVIII Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Recombinant FVIII Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Recombinant FVIII Sales Market Share by Application (2021-2032) Figure 40. North America Recombinant FVIII Revenue Share by Type (2021-2032) Figure 41. North America Recombinant FVIII Sales Share by Type (2021-2032) Figure 42. North America Recombinant FVIII Revenue Share by Application (2021-2032) Figure 43. North America Recombinant FVIII Sales Share by Application (2021-2032) Figure 44. North America Recombinant FVIII Revenue Share by Country (2021-2032) Figure 45. North America Recombinant FVIII Sales Share by Country (2021-2032) Figure 46. Europe Recombinant FVIII Revenue Share by Type (2021-2032) Figure 47. Europe Recombinant FVIII Sales Share by Type (2021-2032) Figure 48. Europe Recombinant FVIII Revenue Share by Application (2021-2032) Figure 49. Europe Recombinant FVIII Sales Share by Application (2021-2032) Figure 50. Europe Recombinant FVIII Revenue Share by Country (2021-2032) Figure 51. Europe Recombinant FVIII Sales Share by Country (2021-2032) Figure 52. China Recombinant FVIII Revenue Share by Type (2021-2032) Figure 53. China Recombinant FVIII Sales Share by Type (2021-2032) Figure 54. China Recombinant FVIII Revenue Share by Application (2021-2032) Figure 55. China Recombinant FVIII Sales Share by Application (2021-2032) Figure 56. Asia Recombinant FVIII Revenue Share by Type (2021-2032) Figure 57. Asia Recombinant FVIII Sales Share by Type (2021-2032) Figure 58. Asia Recombinant FVIII Revenue Share by Application (2021-2032) Figure 59. Asia Recombinant FVIII Sales Share by Application (2021-2032) Figure 60. Asia Recombinant FVIII Revenue Share by Country (2021-2032) Figure 61. Asia Recombinant FVIII Sales Share by Country (2021-2032) Figure 62. SAMEA Recombinant FVIII Revenue Share by Type (2021-2032) Figure 63. SAMEA Recombinant FVIII Sales Share by Type (2021-2032) Figure 64. SAMEA Recombinant FVIII Revenue Share by Application (2021-2032) Figure 65. SAMEA Recombinant FVIII Sales Share by Application (2021-2032) Figure 66. SAMEA Recombinant FVIII Revenue Share by Country (2021-2032) Figure 67. SAMEA Recombinant FVIII Sales Share by Country (2021-2032) Figure 68. Recombinant FVIII Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Recombinant FVIII Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 1000 IU/bottle
  • 2000 IU/bottle
  • 250 IU/bottle
  • 500 IU/bottle
Applications
  • Teenagers
  • Adults
Companies covered
  • Sinocelltech
  • Comirnaty
  • Novo Nordisk
  • Green Cross
  • Bayer
  • Baxter

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Recombinant FVIII Market by Type
  3. 1.2.1 Global Recombinant FVIII Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 1000 IU/bottle
  5. 1.2.3 2000 IU/bottle
  6. 1.2.4 250 IU/bottle
  7. 1.2.5 500 IU/bottle
  8. 1.3 Recombinant FVIII Market by Application
  9. 1.3.1 Global Recombinant FVIII Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Teenagers
  11. 1.3.3 Adults
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Recombinant FVIII Market Dynamics
  1. 2.1 Recombinant FVIII Industry Trends
  2. 2.2 Recombinant FVIII Industry Drivers
  3. 2.3 Recombinant FVIII Industry Opportunities and Challenges
  4. 2.4 Recombinant FVIII Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Recombinant FVIII Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Recombinant FVIII Revenue by Region
  3. 3.2.1 Global Recombinant FVIII Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Recombinant FVIII Revenue by Region (2021-2026)
  5. 3.2.3 Global Recombinant FVIII Revenue by Region (2027-2032)
  6. 3.2.4 Global Recombinant FVIII Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Recombinant FVIII Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Recombinant FVIII Sales by Region
  9. 3.4.1 Global Recombinant FVIII Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Recombinant FVIII Sales by Region (2021-2026)
  11. 3.4.3 Global Recombinant FVIII Sales by Region (2027-2032)
  12. 3.4.4 Global Recombinant FVIII Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Recombinant FVIII Revenue by Manufacturers
  2. 4.1.1 Global Recombinant FVIII Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Recombinant FVIII Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Recombinant FVIII Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Recombinant FVIII Sales by Manufacturers
  6. 4.2.1 Global Recombinant FVIII Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Recombinant FVIII Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Recombinant FVIII Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Recombinant FVIII Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Recombinant FVIII Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Recombinant FVIII Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Recombinant FVIII Manufacturers, Product Type & Application
  13. 4.7 Global Recombinant FVIII Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Recombinant FVIII Market CR5 and HHI
  16. 4.8.2 2025 Recombinant FVIII Tier 1, Tier 2, and Tier 3
5 Recombinant FVIII Market by Type
  1. 5.1 Global Recombinant FVIII Revenue by Type
  2. 5.1.1 Global Recombinant FVIII Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Recombinant FVIII Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Recombinant FVIII Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Recombinant FVIII Sales by Type
  6. 5.2.1 Global Recombinant FVIII Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Recombinant FVIII Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Recombinant FVIII Sales Market Share by Type (2021-2032)
  9. 5.3 Global Recombinant FVIII Price by Type
6 Recombinant FVIII Market by Application
  1. 6.1 Global Recombinant FVIII Revenue by Application
  2. 6.1.1 Global Recombinant FVIII Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Recombinant FVIII Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Recombinant FVIII Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Recombinant FVIII Sales by Application
  6. 6.2.1 Global Recombinant FVIII Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Recombinant FVIII Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Recombinant FVIII Sales Market Share by Application (2021-2032)
  9. 6.3 Global Recombinant FVIII Price by Application
7 Company Profiles
  1. 7.1 Sinocelltech
  2. 7.1.1 Sinocelltech Company Information
  3. 7.1.2 Sinocelltech Business Overview
  4. 7.1.3 Sinocelltech Recombinant FVIII Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sinocelltech Recombinant FVIII Product Portfolio
  6. 7.1.5 Sinocelltech Recent Developments
  7. 7.2 Comirnaty
  8. 7.2.1 Comirnaty Company Information
  9. 7.2.2 Comirnaty Business Overview
  10. 7.2.3 Comirnaty Recombinant FVIII Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Comirnaty Recombinant FVIII Product Portfolio
  12. 7.2.5 Comirnaty Recent Developments
  13. 7.3 Novo Nordisk
  14. 7.3.1 Novo Nordisk Company Information
  15. 7.3.2 Novo Nordisk Business Overview
  16. 7.3.3 Novo Nordisk Recombinant FVIII Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Novo Nordisk Recombinant FVIII Product Portfolio
  18. 7.3.5 Novo Nordisk Recent Developments
  19. 7.4 Green Cross
  20. 7.4.1 Green Cross Company Information
  21. 7.4.2 Green Cross Business Overview
  22. 7.4.3 Green Cross Recombinant FVIII Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Green Cross Recombinant FVIII Product Portfolio
  24. 7.4.5 Green Cross Recent Developments
  25. 7.5 Bayer
  26. 7.5.1 Bayer Company Information
  27. 7.5.2 Bayer Business Overview
  28. 7.5.3 Bayer Recombinant FVIII Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Bayer Recombinant FVIII Product Portfolio
  30. 7.5.5 Bayer Recent Developments
  31. 7.6 Baxter
  32. 7.6.1 Baxter Company Information
  33. 7.6.2 Baxter Business Overview
  34. 7.6.3 Baxter Recombinant FVIII Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Baxter Recombinant FVIII Product Portfolio
  36. 7.6.5 Baxter Recent Developments
8 North America
  1. 8.1 North America Recombinant FVIII Market Size by Type
  2. 8.1.1 North America Recombinant FVIII Revenue by Type (2021-2032)
  3. 8.1.2 North America Recombinant FVIII Sales by Type (2021-2032)
  4. 8.1.3 North America Recombinant FVIII Price by Type (2021-2032)
  5. 8.2 North America Recombinant FVIII Market Size by Application
  6. 8.2.1 North America Recombinant FVIII Revenue by Application (2021-2032)
  7. 8.2.2 North America Recombinant FVIII Sales by Application (2021-2032)
  8. 8.2.3 North America Recombinant FVIII Price by Application (2021-2032)
  9. 8.3 North America Recombinant FVIII Market Size by Country
  10. 8.3.1 North America Recombinant FVIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Recombinant FVIII Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Recombinant FVIII Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Recombinant FVIII Market Size by Type
  2. 9.1.1 Europe Recombinant FVIII Revenue by Type (2021-2032)
  3. 9.1.2 Europe Recombinant FVIII Sales by Type (2021-2032)
  4. 9.1.3 Europe Recombinant FVIII Price by Type (2021-2032)
  5. 9.2 Europe Recombinant FVIII Market Size by Application
  6. 9.2.1 Europe Recombinant FVIII Revenue by Application (2021-2032)
  7. 9.2.2 Europe Recombinant FVIII Sales by Application (2021-2032)
  8. 9.2.3 Europe Recombinant FVIII Price by Application (2021-2032)
  9. 9.3 Europe Recombinant FVIII Market Size by Country
  10. 9.3.1 Europe Recombinant FVIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Recombinant FVIII Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Recombinant FVIII Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Recombinant FVIII Market Size by Type
  2. 10.1.1 China Recombinant FVIII Revenue by Type (2021-2032)
  3. 10.1.2 China Recombinant FVIII Sales by Type (2021-2032)
  4. 10.1.3 China Recombinant FVIII Price by Type (2021-2032)
  5. 10.2 China Recombinant FVIII Market Size by Application
  6. 10.2.1 China Recombinant FVIII Revenue by Application (2021-2032)
  7. 10.2.2 China Recombinant FVIII Sales by Application (2021-2032)
  8. 10.2.3 China Recombinant FVIII Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Recombinant FVIII Market Size by Type
  2. 11.1.1 Asia Recombinant FVIII Revenue by Type (2021-2032)
  3. 11.1.2 Asia Recombinant FVIII Sales by Type (2021-2032)
  4. 11.1.3 Asia Recombinant FVIII Price by Type (2021-2032)
  5. 11.2 Asia Recombinant FVIII Market Size by Application
  6. 11.2.1 Asia Recombinant FVIII Revenue by Application (2021-2032)
  7. 11.2.2 Asia Recombinant FVIII Sales by Application (2021-2032)
  8. 11.2.3 Asia Recombinant FVIII Price by Application (2021-2032)
  9. 11.3 Asia Recombinant FVIII Market Size by Country
  10. 11.3.1 Asia Recombinant FVIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Recombinant FVIII Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Recombinant FVIII Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Recombinant FVIII Market Size by Type
  2. 12.1.1 SAMEA Recombinant FVIII Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Recombinant FVIII Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Recombinant FVIII Price by Type (2021-2032)
  5. 12.2 SAMEA Recombinant FVIII Market Size by Application
  6. 12.2.1 SAMEA Recombinant FVIII Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Recombinant FVIII Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Recombinant FVIII Price by Application (2021-2032)
  9. 12.3 SAMEA Recombinant FVIII Market Size by Country
  10. 12.3.1 SAMEA Recombinant FVIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Recombinant FVIII Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Recombinant FVIII Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Recombinant FVIII Value Chain Analysis
  2. 13.1.1 Recombinant FVIII Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Recombinant FVIII Production Mode & Process
  6. 13.2 Recombinant FVIII Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Recombinant FVIII Distributors
  9. 13.2.3 Recombinant FVIII Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst